Japan’s Global Health Strategy in the Post–COVID-19 Era Vol. 14 | Essential Medical Products during a Public Health Emergency of International Concern (PHEIC): Public Funding for R&D and Internationally Equitable Access to Its Results

This policy brief was originally published in Japanese as part of a series of papers produced by a joint research project conducted by the Japan Center for International Exchange (JCIE) and the Tokyo University Institute for Future Initiatives (IFI) to provide analyses on global and regional health governance systems and structures and to offer concrete recommendations about the role Japan should play in the field of global health.